Samuel White

Dr. Samuel White

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2024 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
SWSamuel White
Samuel White
QPQi Sheng Phua
Qi Sheng Phua
LLLucy Lu
Lucy Lu
KYKaspar L. Yaxley
Kaspar L. Yaxley
MMMatthew D. F. McInnes
Matthew D. F. McInnes
MTMinh-Son To
Minh-Son To
Importance: Systematic reviews of medical imaging diagnostic test accuracy (DTA) studies are affected by between-study heterogeneity due to a range of factors. Failure to appropriately assess the extent and causes of heterogeneity compromises the interpretability of systematic review findings.Objective: To assess how heterogeneity has been examined in medical imaging DTA studies.Evidence Review: The PubMed database was searched for systematic reviews of medical imaging DTA studies that performed a meta-analysis. The search was limited to the 40 journals with highest impact factor in the radiology, nuclear medicine, and medical imaging category in the InCites Journal Citation Reports of 2021 to reach a sample size of 200 to 300 included studies. Descriptive analysis was performed to characterize the imaging modality, target condition, type of meta-analysis model used, strategies for evaluating heterogeneity, and sources of heterogeneity identified. Multivariable logistic regression was performed to assess whether any factors were associated with at least 1 source of heterogeneity being identified in the included meta-analyses. Methodological quality evaluation was not performed. Data analysis occurred from October to December 2022.Findings: A total of 242 meta-analyses involving a median (range) of 987 (119-441 510) patients across a diverse range of disease categories and imaging modalities were included. The extent of heterogeneity was adequately described (ie, whether it was absent, low, moderate, or high) in 220 studies (91%) and was most commonly assessed using the I2 statistic (185 studies [76%]) and forest plots (181 studies [75%]). Heterogeneity was rated as moderate to high in 191 studies (79%). Of all included meta-analyses, 122 (50%) performed subgroup analysis and 87 (36%) performed meta-regression. Of the 242 studies assessed, 189 (78%) included 10 or more primary studies. Of these 189 studies, 60 (32%) did not perform meta-regression or subgroup analysis. Reasons for being unable to investigate sources of heterogeneity included inadequate reporting of primary study characteristics and a low number of included primary studies. Use of meta-regression was associated with identification of at least 1 source of variability (odds ratio, 1.90; 95% CI, 1.11-3.23; P = .02).Conclusions and Relevance: In this systematic review of assessment of heterogeneity in medical imaging DTA meta-analyses, most meta-analyses were impacted by a moderate to high level of heterogeneity, presenting interpretive challenges. These findings suggest that, despite the development and availability of more rigorous statistical models, heterogeneity appeared to be incomplete, inconsistently evaluated, or methodologically questionable in many cases, which lessened the interpretability of the analyses performed; comprehensive heterogeneity assessment should be addressed at the author level by improving personal familiarity with appropriate statistical methodology for assessing heterogeneity and involving biostatisticians and epidemiologists in study design, as well as at the editorial level, by mandating adherence to methodologic standards in primary DTA studies and DTA meta-analyses.

20 July 2020 in Biophysical Reviews
Verified
Journal Article
Closed access
PDF file
SWSamuel White
Samuel White
JCJames J. H. Chong
James J. H. Chong

27 December 2024 in Journal of Clinical Epidemiology
Verified
Journal Article
Open access
SWSamuel White
Samuel White
MCMinh Chau
Minh Chau
EAElio Arruzza
Elio Arruzza
MOMervyn Ong
Mervyn Ong
HJHritik John
Hritik John
MTMinh-Son To
Minh-Son To
The Standards for Reporting of Diagnostic Accuracy (STARD) 2015 guideline facilitates evaluation of key aspects of diagnostic test accuracy (DTA) studies and their findings, including the risk of bias and applicability of findings. To evaluate the completeness of reporting in medical imaging DTA research in a sample of studies published in 2023. A systematic search of Medline, Embase, and the Cochrane Library was performed to identify medical imaging DTA studies published between January and June 2023 that assessed one or more index imaging tests compared to a reference standard and reported test performance using relevant outcome measures. Completeness of reporting amongst the included studies was assessed using the 30-item STARD-2015 guideline. Multiple linear regression was subsequently performed to identify study characteristics associated with more complete reporting. A total of 116 studies were included in our analysis with a median journal impact factor of 2.7 (range 0.9-19.7). The mean number of items reported was 17.5/30 (58%, SD 2.2). Items that were infrequently reported (reported in less than 33% of included studies) included items 9 ('whether participants formed a consecutive, random or convenience series'), 13.2 ('whether clinical information and index test results were available to the assessors of the reference standard'), 15 ('how indeterminate index test or reference standard results were handled'), 16 ('how missing data on the index test and reference standard were handled'), 22.1 ('time interval between the index test and the reference standard'), 22.2 ('clinical interventions between the index test and the reference standard') and 29 ('where the full study protocol can be accessed'). Adherence was significantly higher in journals with a higher than median journal impact factor (18.1/30 vs 16.8/30 items reported; P < .001). The completeness of reporting in medical imaging DTA research is moderate and remains relatively static in absolute terms compared to a previous evaluation of studies published in 2016 performed by Hong and colleagues, acknowledging differences in sample study characteristics limit direct comparison. Potential strategies to support more complete reporting in medical imaging DTA research include mandating adherence to the STARD guideline in journal instructions to authors, requiring completed STARD checklists to be submitted alongside all DTA study manuscripts, and integrating quality of reporting assessment as a routine component of the peer review process.

6 February 2026 in Radiography
Verified
Journal Article
Open access
MCMinh Chau
Minh Chau
KBKelly Bentley-Spuur
Kelly Bentley-Spuur
SWSamuel White
Samuel White
APAlicia Pyper
Alicia Pyper
DCDr Mason Crossman
Dr Mason Crossman
Artificial intelligence (AI) and machine learning (ML) are increasingly integrated into diagnostic imaging. This review examines how AI adoption affects malpractice risk, the legal standard of care, liability distribution, and informed consent. It also evaluates regulatory developments and ethical concerns, including explicability, autonomy, and professional accountability. AI-supported image interpretation can improve diagnostic accuracy and efficiency. Its integration is reshaping expectations of reasonable clinical practice, with the potential for negligence claims both when clinicians fail to use validated systems and when they rely on insufficiently tested tools. Liability is uncertain because diagnostic responsibility is distributed across clinicians, healthcare organisations, and developers. Existing negligence frameworks assume human reasoning and struggle to accommodate opaque algorithmic decision-making, limiting courts' ability to assess whether AI-assisted diagnoses meet accepted standards. "Black box" models heighten automation bias, hinder legal scrutiny of error, and complicate professional accountability. Informed consent case law suggests AI involvement should be disclosed when it introduces material differences in risk or outcome, although this remains inconsistently applied. Ethical challenges include threats to patient trust, potential clinician deskilling, and reduced transparency in clinical communication. Regulatory initiatives such as the European Union's General Data Protection Regulation and AI Act move toward clearer governance through requirements for data quality, human oversight, and post-market monitoring, yet explicit malpractice guidance remains under-developed globally. Traditional legal and ethical frameworks insufficiently address accountability for AI-driven diagnostic errors. Clarifying responsibility, decision authority, and validation requirements is essential to safeguard patient safety and clinician protection. Clinical protocols should specify approved use cases, oversight expectations, documentation of AI involvement, and management of clinician-algorithm disagreement. Training should support critical review of outputs to mitigate automation bias.

7 September 2023 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
SWSamuel White
Samuel White
ATAjay Taranath
Ajay Taranath
PHPrasad Hanagandi
Prasad Hanagandi
DTDeepa A. Taranath
Deepa A. Taranath
MTMinh-Son To
Minh-Son To
JCJamie E. Craig
Jamie E. Craig
SUMMARY: Axenfeld-Rieger syndrome is an autosomal dominant condition associated with multisystemic features including developmental anomalies of the anterior segment of the eye. Single nucleotide and copy number variants in the paired-like homeodomain transcription factor 2 (PITX2) and forkhead box C1 (FOXC1) genes are associated with Axenfeld-Rieger syndrome as well as other CNS malformations. We determined the association between Axenfeld-Rieger syndrome and specific brain MR imaging neuroradiologic anomalies in cases with or without a genetic diagnosis. This case series included 8 individuals with pathogenic variants in FOXC1; 2, in PITX2; and 2 without a genetic diagnosis. The most common observation was vertebrobasilar artery dolichoectasia, with 46% prevalence. Other prevalent abnormalities included WM hyperintensities, cerebellar hypoplasia, and ventriculomegaly. Vertebrobasilar artery dolichoectasia and absent/hypoplastic olfactory bulbs were reported in >50% of individuals with FOXC1 variants compared with 0% of PITX2 variants. Notwithstanding the small sample size, neuroimaging abnormalities were more prevalent in individuals with FOXC1 variants compared those with PITX2 variants.

7 March 2026 in European Journal of Radiology
Verified
Journal Article
Open access
SWSamuel White
Samuel White
KYKaspar L. Yaxley
Kaspar L. Yaxley
MTMinh-Son To
Minh-Son To
MCMinh Chau
Minh Chau
Artificial intelligence (AI) is increasingly embedded in radiology research and practice, yet concerns about the reproducibility of AI studies remain a key barrier to regulatory acceptance and clinical translation. Transparent reporting across the analytic pipeline is essential for independent verification, evidence synthesis, and safe implementation. To examine major barriers to transparent reporting in radiological AI research and propose practical solutions to strengthen reproducibility. We identify four interrelated challenges undermining reporting quality. First, reporting is often treated as a final-stage manuscript requirement rather than a prospectively embedded component of study design, leading to loss of methodological detail. Second, inconsistent operationalization of reporting standards by journals and funders makes it difficult to assess reporting completeness. Third, fragmentation and overlapping complexity of AI-specific reporting guidelines increase interpretive burden for authors and reviews and contribute to heterogeneity in reporting. Fourth, limited availability and usability of data and code restrict independent verification, even when resources are nominally shared. These issues are amplified by the methodological complexity and heterogeneity of radiological AI pipelines. For each challenge, we outline actionable strategies including prospective documentation of methods, mandatory and consistently applied reporting standards, harmonized reporting principles, and clearer requirements for data and code availability with structured alternatives when sharing is constrained. Strengthening transparent reporting is a prerequisite for reproducible and clinically translatable radiological AI research. Embedding reporting within study design, aligning stakeholder expectations, and improving access to reproducibility-enabling resources are essential to enhance credibility, facilitate independent evaluation, and support safe clinical implementation of AI in radiology.